JPMorgan Chase & Co’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-298,323
| Closed | -$16.4M | – | 6141 |
|
|
2022
Q2 | $16.4M | Buy |
+298,323
| New | +$16.4M | ﹤0.01% | 1564 |
|
|
2022
Q1 | – | Sell |
-1,300
| Closed | -$28K | – | 6189 |
|
|
2021
Q4 | $28K | Buy |
1,300
+1,200
| +1,200% | +$25.8K | ﹤0.01% | 5248 |
|
|
2021
Q3 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 5413 |
|
|
2019
Q4 | – | Sell |
-6
| Closed | – | – | 4942 |
|
|
2019
Q3 | $0 | Sell |
6
-1,087
| -99% | – | ﹤0.01% | 4980 |
|
|
2019
Q2 | $25K | Buy |
1,093
+992
| +982% | +$22.7K | ﹤0.01% | 4484 |
|
|
2019
Q1 | $7K | Buy |
+101
| New | +$7K | ﹤0.01% | 4683 |
|
|
2018
Q4 | – | Sell |
-3,640
| Closed | -$248K | – | 5041 |
|
|
2018
Q3 | $248K | Sell |
3,640
-1,683
| -32% | -$115K | ﹤0.01% | 3786 |
|
|
2018
Q2 | $630K | Sell |
5,323
-224
| -4% | -$26.5K | ﹤0.01% | 3355 |
|
|
2018
Q1 | $459K | Buy |
5,547
+5,541
| +92,350% | +$459K | ﹤0.01% | 3417 |
|
|
2017
Q4 | $1K | Sell |
6
-813
| -99% | -$136K | ﹤0.01% | 4633 |
|
|
2017
Q3 | $51K | Buy |
819
+813
| +13,550% | +$50.6K | ﹤0.01% | 3796 |
|
|
2017
Q2 | $0 | Sell |
6
-95
| -94% | – | ﹤0.01% | 4591 |
|
|
2017
Q1 | $6K | Sell |
101
-687
| -87% | -$40.8K | ﹤0.01% | 4273 |
|
|
2016
Q4 | $47K | Sell |
788
-3,251
| -80% | -$194K | ﹤0.01% | 4041 |
|
|
2016
Q3 | $294K | Buy |
+4,039
| New | +$294K | ﹤0.01% | 3150 |
|
|
2016
Q2 | – | Sell |
-103
| Closed | -$28K | – | 4415 |
|
|
2016
Q1 | $28K | Buy |
+103
| New | +$28K | ﹤0.01% | 3535 |
|